Open Access

Long noncoding RNAs in DNA methylation: new players stepping into the old game

Cell & Bioscience20166:45

https://doi.org/10.1186/s13578-016-0109-3

Received: 26 May 2016

Accepted: 2 June 2016

Published: 11 July 2016

Abstract

Long non-coding RNAs (lncRNAs) are being discovered as a novel family of regulators of gene expression at the epigenetic level. Emerging lines of evidence demonstrate that interplays between lncRNAs and DNA methylation machinery are an important layer of epigenetic regulation. Here in this mini-review we summarize the current findings in the field and focus particularly on the interactions mediated through direct physical association between lncRNAs and DNA methyltransferases (DNMTs).

Keywords

lncRNAs Dnmt Methylation Epigenetics

Background

DNA methylation is one of fundamental epigenetic mechanisms to regulate gene transcription, which involves the addition of methyl group to cytosines that are typically restricted to CpG dinucleotides [1]. The CpG-rich regions in genome, referred to as CpG islands, often occur at promoter and first-exon regions and are normally unmethylated; when they become methylated, the transcription of the cognate genes will be blocked [2, 3]. The establishment and maintenance of methylation patterns resulting in modulation of gene expression is one of the key steps in epigenetic regulation during normal development programs. Such process is precisely orchestrated by several DNA methyltransferases (DNMTs). In mammalian cells, DNMT3a and DNMT3b are known to de novo establish DNA methylation pattern whereas DNMT1 acts to maintain methylation status during DNA replication [4, 5]. It is now clear that dynamic changes in DNA methylation accompany development and other pathophysiological processes [6, 7]. For example, low methylation level was found at CpG-rich sequences at the pluripotency state of embryonic stem cells (ESCs); when differentiation processes ensue into the three germ layers, a global gain of DNA methylation occurs at the specific regions [7, 8]. In the absence of DNMTs, ESCs are competent for self-renewal but fail to initiate cellular differentiation [810]. Despite a wealth of knowledge on the dynamic changes of DNA methylation in diverse settings, there is still limited understanding of the mechanisms to determine the DNA regions targeted by DNMTs since they lack any sequence specificity other than CpG dinucleotides [4]. The interaction between histone modifiers and DNMTs provides one solution for the achieved sequence specificity. For example, EZH2 (a component of Polycomb Repressive Complex 2) was shown to interact with DNMTs and the presence of EZH2 is crucial for DNA methylation at EZH2-target promoters [11]. The H3K9 methyltransferase SETDB1 also directly associates with DNMT3a/b and their co-binding was observed at RASSF1 promoter [12]. Recently, genome-wide DNA methylation profiles during cell differentiation have revealed the differentially methylated regions are enriched for transcription factor binding sites, implying potential roles of transcription factors in dictating the changes of DNA methylation landscape, which is supported by several pieces of experimental evidence [3, 13, 14]. For instance, E2F6 was found to recruit DNMT3B to a subset of germline gene promoters in somatic tissue, leading to the DNA methylation and the silenced state [15]. Notwithstanding these advances, key questions regarding how sequence-specific DNA methylation is orchestrated and whether additional players are involved remain largely unsolved. The novel family of regulators of gene expression, long non-coding RNAs (lncRNAs) seem to fill the gap.

A major advance in molecular biology over the past two decades has been the discovery and characterization of function for lncRNAs. The extraordinary maturation in sequencing technology, allowing the detection of low abundance transcripts in genome-wide transcriptomes analyses via massive parallel sequencing, has revealed significant levels of transcriptional activity within the unannotated and annotated regions of genome. Among many of the newly discovered non-coding transcripts, lncRNAs are the transcripts with a length over 200 nt, normally poorly conserved and do not serve as the templates for protein synthesis [1619]. According to their genomic loci relative to protein-coding counterparts, lncRNAs can be further categorized as long intergenic ncRNAs (lincRNAs), antisense lncRNAs and intronic lncRNAs (Fig. 1) [16, 17]. Many of them are capped, spliced and polyadenylated similar to mRNAs. Recently, another class of lncRNAs, termed enhancer RNAs (eRNAs) generated from regulatory regions of genome, is emerging as important players in transcriptional activation of target mRNAs [2022]. However, they are normally not spliced or polyadenylated. LncRNAs have been implicated in playing essential roles in every aspect of cellular processes and regulate gene expressions at different levels including chromatin organization, transcriptional control and post-transcriptional regulation (Fig. 1) [17]. The function of lncRNAs cannot currently be predicted from sequence information alone. An emerging theme, however, is the capacity of lncRNAs to modulate gene expression, with many of them participating in epigenetic control through interacting with various types of proteins involved in histone modification or chromatin remodeling. In particular, the Polycomb Repressive Complex 2 (PRC2), which is essential for embryonic development, binds numerous lncRNAs [2325], fueling the idea that lncRNAs might be involved in targeting PRC2 to specific gene control elements. For instance, the lncRNA Xist (X-inactivation specific transcripts) binds to PRC2 to deposit repressive histone marks H3K27me3 along the X chromosome followed by inactivation of the marked copy, a mechanism required for dosage compensation in (mammalian) females [26, 27]. In addition to acting in epigenetic control through chromatin modification, emerging evidence has uncovered the underlying crosstalk between lncRNAs and DNA methylation. In this short review, we aim to summarize the relevant findings in this field emphasizing on those lncRNAs that have been identified to physically interact with DNMTs to regulate DNA methylation.
Fig. 1

Genomic context and mechanisms of action of lncRNAs. a LncRNAs can be categorized according to their genomic loci relative to protein-coding genes. Intergenic lncRNAs (lincRNAs) are separate transcription units from protein-coding genes. Among them, a class may be transcribed from enhancers (eRNAs). Intronic lncRNAs are generated from the introns of protein-coding genes without overlapping with exons. Antisense lncRNAs are transcribed in opposite direction of protein-coding genes and overlap with the exons. Divergent lncRNAs are normally initiated from the promoter region of protein-coding genes. b LncRNAs exploit distinct mechanisms to elicit their regulatory roles in gene expression. lncRNAs can recruit proteins such as chromatin modifiers to target DNA; lncRNAs may act as decoy to titrate away DNA binding proteins like transcription factors; lncRNAs can function as scaffold to bring multiple proteins into a complex; to organize higher-order nuclear structure; eRNAs can interact with Mediator and/or Cohesin complex to mediate and/or stabilize chromosomal looping between enhancers and cognate promoters. In cytoplasm, lncRNAs can influence translation through intervening the loading of polysomes to mRNAs; lncRNAs can serve as miRNA sponges to release their inhibitory roles on target mRNAs; lncRNAs can regulate mRNA decay pathway, stabilizing or destabilizing mRNAs through RNA/RNA interaction with mRNA

ecCEBP

An outstanding example comes from a paper published in Nature [28], Di Ruscio and colleagues reported that a class of non-polyadenylated RNAs can regulate DNA methylation at a locus-specific pattern through interacting with DNMT1. In their findings, a nuclear-enriched lncRNA termed ecCEBP (extra-coding CEBPA) is expressed from CEBPA locus and shares a concordant expression pattern with CEBPA in human tissues. Silencing of this lncRNA diminishes the expression of CEBPA, suggesting its activating role. CEBPA is a known factor subject to the regulation of DNA methylation. Intriguingly, depletion of ecCEBP results in the increased methylation intensity at CEBPA promoter region. Moreover, overexpression of a region of ecCEBP is sufficient to alleviate the methylation level at the CEBPA locus and in turn increase the CEBPA expression. It is worthy to note that regulation of DNA methylation by ecCEBP is specific to the locus, since other genomic regions show little changes in DNA methylation pattern upon ecCEBP perturbation. Additionally, the authors demonstrated that ecCEBPA is physically associated with DNMT1; a subsequent detailed analysis revealed the DNMT1 with ecCEBPA RNA domains that assumed a stem-loop structure and mapped the RNA binding interface to a region encompassing the DNMT1 catalytic domain. Finally, the authors assessed the DNMT1-interacting RNAs at a genome-wide level by performing RIP followed by high throughput sequencing. Interestingly, they found an anti-correlation between DNMT1/RNA interaction and the methylation level at corresponding locus [28]. Taken together, this study has provided solid evidence for a model in which a class of non-polyadenylated lncRNAs regulate DNA methylation patterns through their association with DNMT1.

Dali

Another example of DNMT1-interacting lncRNA comes from a recent publication from Chalei and colleagues [29]. In this study Chalei et al. revealed that a central nervous system-expressed lncRNA termed Dali is essential for neural differentiation and can regulate neural gene expression partially through interacting with DNMT1 to affect DNA methylation at distal target promoters. Notably, in this study the authors characterized Dali-associated DNA regions at a genome-wide level. They found Dali is associated with active chromatins revealed by the evidence that Dali bound regions are enriched for active histone marks like H3K4me3, H3K4me1 and H3K27ac. Additionally, the authors performed computational analysis to exclude the possibility that Dali directly interacts with DNA. On the contrary, they identified Dali interactions with DNMT1 to bring it to DNA regions; depletion of Dali increases DNA methylation at a subset of gene promoters, suggesting its inhibitory role in DNA methylation. Of note, the target promoters under Dali control are away from its site of transcription, indicating Dali modulates DNA methylation in trans. DNMT1 interacting transcription factors were thought to be required to target DNMT1 to specific loci. Interestingly, binding motifs of 9 such transcription factors are enriched in Dali-bound DNA regions, sparking a possibility that these factors determine the specificity of Dali-mediated DNA methylation change. These observations led to a model that lncRNA influences DNA methylation in trans at distal DNA regions through harnessing DNMT1 machinery [29].

Dum

While the above studies were focused on DNMT1, the maintenance enzyme, other DNA methyltransferases enzymes may also associate with lncRNAs, which may modulate their enzymatic activity and the patterns of de novo DNA methylation. Indeed, a very recent report [30] from our group identified a lncRNA, Dum which coordinates the skeletal myoblast differentiation program through interacting with several DNMTs including DNMT1, DNMT3a and DNMT3b. In this work, we found Dum is induced by MyoD with an increased expression during differentiation process. Silencing of Dum impinges on myogenic differentiation in vitro and muscle regeneration in vivo, suggesting its pro-myogenic role. Additionally, Dum knockdown influenced the expression of several nearby genes, favoring a cis-action mode; and Dppa2 was found to be a profound downstream target to recapitulate the roles of Dum in myogenesis. Dppa2 was reported to be regulated by DNA methylation and our mechanistic studies revealed it is controlled by the interaction between Dum and the DNMTs. Depletion of Dum remarkably impaired the binding of DNMTs to the CpG regions of Dppa2 promoter; while using chromatin isolation by RNA purification (ChIRP) assay, we retrieved Dppa2 promoter regions, substantiating the indispensable role of Dum in DNMTs regulation on Dppa2 promoter region. Of note, Dum/Dppa2 interaction requires the intra-chromosomal looping between these two loci. Cohesin components, NIPBL and RAD21, were shown to occupy both Dppa2 and Dum regions and knockdown of the factors attenuated the repression of Dppa2 expression, suggesting the long-range chromosomal interaction is required for the repressive role of Dum on Dppa2 locus. Collectively, our study expands the concept of DNMT-interacting lncRNAs and suggests chromatin looping may be necessary to target the lncRNAs to particular loci [30].

Dacor1

Besides these findings to dissect the connections between individual lncRNAs and DNMTs, it will be of great interest to identify the DNMT-interacting lncRNAs genome-widely. Indeed, the latest work done by Merry et al. [31] uncovered a total of 148 lncRNAs that are associated with DNMT1 in colon cancer cell through RNA immunoprecipitation sequencing (RIP-seq). Among them, the authors identified one lncRNA, referred to as DACOR1 (DNMT1-associated Colon Cancer Repressed lncRNA 1), that is highly and specifically expressed in normal colon tissue while repressed in colon cancer cell lines. Intriguingly, overexpression of DACOR1 in colon cancer cells resulted in a gain of DNA methylation at multiple loci without changing the DNMT1 expression level. Through ChIRP-seq (ChIRP sequencing) analysis, the authors demonstrated that DACOR1 occupies a total of 338 genomic loci, of which 161 peaks are near 150 annotated genes. Notably, 31 of these sites overlapped with differentially methylated regions (DMRs) previously found in colon cancer samples versus matched normal tissues. These findings indicate that DACOR1, via its interaction with both chromatin and DNMT1, targets DNMT1 protein complex to the right genomic loci. Moreover, DACOR1 was found to repress the expression of Cystathionine β-synthase (CBS) and in turn increase methionine, which is the substrate to produce S-adenosyl methionine (SAM). SAM is the key methyl donor for DNA methylation in mammalian cells. Thus, DACOR1 may also impinge on DNA methylation through orchestrating cellular SAM levels [31].

LincRNA-p21

In addition to the above examples of lncRNAs which regulate DNA methylation through physical association with DNMTs, many other lncRNAs may participate in modulating DNA methylation indirectly through interacting with other RNA binding proteins. A prominent example comes from a recent report from Bao and colleagues [32]. In their work, Bao et al. unraveled the mechanisms underlying lincRNA-p21 functions in somatic cell reprogramming. They found lincRNA-p21 is induced by p53 but not affect cell apoptosis or cell senescence. Instead, lincRNA-p21 impedes cell reprogramming by maintaining the repressive histone mark H3K9me3 or DNA methylation at the promoters of different sets of pluripotent genes. Mechanistically, such actions are mediated via the interactions of lincRNA-p21 with H3K9 methyltransferase SETDB1 and DNMT1 respectively, both of which are dependent on the RNA binding protein hnRNPk. Knockdown of hnRNPk attenuated the association between lincRNA-p21 with SETDB1 or DNMT1 and in turn enhanced reprogramming efficiency. Hence, hnRNPk serves as a platform facilitating the connection between lincRNA-p21 and DNMT1 to promote DNA methylation at specific loci [32].

Other lncRNAs involved in DNA methylation

Another well-known lncRNA that affects DNA methylation is Kcnq1ot1, transcribed from the paternal allele of the imprinted Kcnq1 locus. Besides the Kcnq1 gene, this locus encodes eight other genes that are either ubiquitously or placental-specifically imprinted in a Kcnq1ot1-expression-dependent manner [33]. An 890 nt region close to the 5′ end of Kcnq1ot1 is important for silencing and its genetic deletion in mice leads to abnormal silencing of ubiquitously imprinted genes, where a decrease in DNMT1 recruitment and subsequent reduction of CpG methylation occur [34]. However, a direct DNMT1–Kcnq1ot1 interaction has not been demonstrated. Additionally, a recently characterized lncRNA PARTICLE (promoter of MAT2A-antisense radiation-induced circulating lncRNA) [35] forms a DNA-lncRNA triplex upstream of a MAT2A promoter CpG island and represses MAT2A via methylation. Interestingly, MAT2A gene encodes the catalytic subunit of methionine adenosyltransferase which is an essential enzyme in methylation cycle. It means that lncRNA could interact with DNA methylation to regulate the expression of the methylation-modifying player, reflecting the close relationship between lncRNA and DNA methylation. Instead of showing the direct interaction between PARTICLE and DNMTs, the authors found that PARTICLE could interact with several chromatin suppressors such as G9a and SUZ12 (subunit of PRC2) thus serving as a recruiting platform for gene silencing complex. However, whether the methylation of MAT2A by PARTICLE was mediated by these chromatin suppressive proteins remains to be confirmed [35]. In addition to causing DNA methylation to silence gene expression, lncRNAs could also participate in demethylation leading to gene activation. For example, an antisense lncRNA, TARID (for TCF21 antisense RNA inducing demethylation), could activates TCF21 transcription by inducing demethylation of the TCF21 promoter [36]. Mechanistically, it occurs through TARID binding to the TCF21 promoter and recruiting GADD45A, which then recruits TDG together with TETs to direct base excision repair for demethylation.

Conclusions

In conclusion, as modeled in Fig. 2, lncRNAs can modulate the DNA methylation through interacting with diverse DNMT members directly or indirectly. Through the action of recruitment or eviction they may either promote or repress DNA methylation in cis or in trans. The dynamic nature of lncRNA repertoire as well as the RNA plasticity in interacting with diverse molecules such as DNA, RNA and protein renders lncRNA an ideal mediator to regulate local and sequence-specific DNA methylation or demethylation, hence resulting in global changes in DNA methylation profile, through which cells can respond to diverse stimuli. In the future we anticipate that many other lncRNAs will be discovered to be involved in DNA methylation control. The dysregulation of these lncRNAs may trigger epigenetic disorders in various human diseases. Therefore, the future efforts in studying the regulatory roles of lncRNAs in epigenetic mechanisms will open new avenues for therapeutic targets for DNA methylation processes.
Fig. 2

The regulatory mechanisms of DNA methylation by lncRNAs. a lncRNA/DNMT1 interaction prevents locus-specific DNA methylation locally in cis (for example, ecCEBP). b lncRNA/DNMT1 interaction modulates DNA-methylation at distant genomic loci in trans, which may also require DNMT1-associated transcription factors (TFs) (for example, Dali). c lncRNA interacts with all three DNMTs (DNMT1, DNMT3a and 3b) to mediate/maintain local DNA methylation at the target promoter (for example, Dum). d lncRNA interacts with DNMT1 indirectly through a protein intermediate (for example, lincRNA-p21)

Abbreviations

CBS: 

cystathionine β-synthase

ChIRP: 

chromatin isolation by RNA purification

DACOR1: 

DNMT1-associated colon cancer repressed lncRNA 1

DNMT: 

DNA methyltransferase

ecCEBP: 

extra-coding CEBPA

eRNA: 

enhancer RNA

ESC: 

embryonic stem cell

lincRNA: 

long intergenic ncRNA

lncRNA: 

long noncoding RNA

PARTICLE: 

promoter of MAT2A-antisense radiation-induced circulating lncRNA

PRC2: 

polycomb repressive complex 2

RIP-seq: 

RNA immunoprecipitation sequencing

SAM: 

S-adenosyl methionine

TARID: 

TCF21 antisense RNA inducing demethylation

Xist: 

X-inactivation specific transcripts

Declarations

Authors’ contributions

YZ drafted the manuscript. HS and HW edited and revised the manuscript. All authors read and approved the final manuscript.

Availability of data and material

None.

Competing interests

The authors declare that they have no competing interests.

Funding

The work described in this paper was substantially supported by four General Research Funds (GRF) to HW and HS from the Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China (Project number: 2140874 to HW, 2140806 and 2140861 to HS); One Collaborative Research Fund (CRF) to HW and HS from RGC (Project number: C6015-14G); and one Grant from the Ministry of Science and Technology of China 973 Program (2014CB964700) to HW.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong
(2)
Department of Chemical Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong
(3)
Department of Orthopedics and Traumatology, Prince of Wales Hospital, The Chinese University of Hong Kong

References

  1. Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci. 2006;31(2):89–97.View ArticlePubMedGoogle Scholar
  2. Lister R, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature. 2009;462(7271):315–22.View ArticlePubMedPubMed CentralGoogle Scholar
  3. Ziller MJ, et al. Charting a dynamic DNA methylation landscape of the human genome. Nature. 2013;500(7463):477–81.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Shen H, Laird PW. Interplay between the cancer genome and epigenome. Cell. 2013;153(1):38–55.View ArticlePubMedPubMed CentralGoogle Scholar
  5. Bedi U, et al. Epigenetic plasticity: a central regulator of epithelial-to-mesenchymal transition in cancer. Oncotarget. 2014;5(8):2016–29.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Xie W, et al. Epigenomic analysis of multilineage differentiation of human embryonic stem cells. Cell. 2013;153(5):1134–48.View ArticlePubMedPubMed CentralGoogle Scholar
  7. Meissner A, et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature. 2008;454(7205):766–70.PubMedPubMed CentralGoogle Scholar
  8. Fouse SD, et al. Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex and histone H3 K4/K27 trimethylation. Cell Stem Cell. 2008;2(2):160–9.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Tsumura A, et al. Maintenance of self-renewal ability of mouse embryonic stem cells in the absence of DNA methyltransferases Dnmt1, Dnmt3a and Dnmt3b. Genes Cells. 2006;11(7):805–14.View ArticlePubMedGoogle Scholar
  10. Jackson M, et al. Severe global DNA hypomethylation blocks differentiation and induces histone hyperacetylation in embryonic stem cells. Mol Cell Biol. 2004;24(20):8862–71.View ArticlePubMedPubMed CentralGoogle Scholar
  11. Vire E, et al. The polycomb group protein EZH2 directly controls DNA methylation. Nature. 2006;439(7078):871–4.View ArticlePubMedGoogle Scholar
  12. Li H, et al. The histone methyltransferase SETDB1 and the DNA methyltransferase DNMT3A interact directly and localize to promoters silenced in cancer cells. J Biol Chem. 2006;281(28):19489–500.View ArticlePubMedGoogle Scholar
  13. Hogart A, et al. Genome-wide DNA methylation profiles in hematopoietic stem and progenitor cells reveal overrepresentation of ETS transcription factor binding sites. Genome Res. 2012;22(8):1407–18.View ArticlePubMedPubMed CentralGoogle Scholar
  14. Feldmann A, et al. Transcription factor occupancy can mediate active turnover of DNA methylation at regulatory regions. PLoS Genet. 2013;9(12):e1003994.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Velasco G, et al. Dnmt3b recruitment through E2F6 transcriptional repressor mediates germ-line gene silencing in murine somatic tissues. Proc Natl Acad Sci USA. 2010;107(20):9281–6.View ArticlePubMedPubMed CentralGoogle Scholar
  16. Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem. 2012;81:145–66.View ArticlePubMedGoogle Scholar
  17. Kung JT, Colognori D, Lee JT. Long noncoding RNAs: past, present and future. Genetics. 2013;193(3):651–69.View ArticlePubMedPubMed CentralGoogle Scholar
  18. Flynn RA, Chang HY. Long noncoding RNAs in cell-fate programming and reprogramming. Cell Stem Cell. 2014;14(6):752–61.View ArticlePubMedPubMed CentralGoogle Scholar
  19. Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2014;15(1):7–21.View ArticlePubMedGoogle Scholar
  20. Lam MT, et al. Enhancer RNAs and regulated transcriptional programs. Trends Biochem Sci. 2014;39(4):170–82.View ArticlePubMedPubMed CentralGoogle Scholar
  21. Kim TK, et al. Widespread transcription at neuronal activity-regulated enhancers. Nature. 2010;465(7295):182–7.View ArticlePubMedPubMed CentralGoogle Scholar
  22. Wang D, et al. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature. 2011;474(7351):390–4.View ArticlePubMedPubMed CentralGoogle Scholar
  23. Zhao J, et al. Genome-wide identification of polycomb-associated RNAs by RIP-seq. Mol Cell. 2010;40(6):939–53.View ArticlePubMedPubMed CentralGoogle Scholar
  24. Khalil AM, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci USA. 2009;106(28):11667–72.View ArticlePubMedPubMed CentralGoogle Scholar
  25. Cifuentes-Rojas C, et al. Regulatory interactions between RNA and polycomb repressive complex 2. Mol Cell. 2014;55(2):171–85.View ArticlePubMedPubMed CentralGoogle Scholar
  26. Zhao J, et al. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science. 2008;322(5902):750–6.View ArticlePubMedPubMed CentralGoogle Scholar
  27. Jeon Y, Lee JT. YY1 tethers Xist RNA to the inactive X nucleation center. Cell. 2011;146(1):119–33.View ArticlePubMedPubMed CentralGoogle Scholar
  28. Di Ruscio A, et al. DNMT1-interacting RNAs block gene-specific DNA methylation. Nature. 2013;503(7476):371.View ArticlePubMedPubMed CentralGoogle Scholar
  29. Chalei V, et al. The long non-coding RNA Dali is an epigenetic regulator of neural differentiation. Elife. 2014;3:e04530.View ArticlePubMedPubMed CentralGoogle Scholar
  30. Wang LJ, et al. LncRNA Dum interacts with Dnmts to regulate Dppa2 expression during myogenic differentiation and muscle regeneration. Cell Res. 2015;25(3):335–50.View ArticlePubMedPubMed CentralGoogle Scholar
  31. Merry CR, et al. DNMT1-associated long non-coding RNAs regulate global gene expression and DNA methylation in colon cancer. Hum Mol Genet. 2015;24(21):6240–53.View ArticlePubMedGoogle Scholar
  32. Bao XC, et al. The p53-induced lincRNA-p21 derails somatic cell reprogramming by sustaining H3K9me3 and CpG methylation at pluripotency gene promoters. Cell Res. 2015;25(1):80–92.View ArticlePubMedGoogle Scholar
  33. Mancini-Dinardo D, et al. Elongation of the Kcnq1ot1 transcript is required for genomic imprinting of neighboring genes. Genes Dev. 2006;20(10):1268–82.View ArticlePubMedPubMed CentralGoogle Scholar
  34. Mohammad F, et al. Kcnq1ot1 noncoding RNA mediates transcriptional gene silencing by interacting with Dnmt1. Development. 2010;137(15):2493–9.View ArticlePubMedGoogle Scholar
  35. O’Leary VB, et al. PARTICLE, a triplex-forming long ncrna, regulates locus-specific methylation in response to low-dose irradiation. Cell Rep. 2015;11(3):474–85.View ArticlePubMedGoogle Scholar
  36. Arab K, et al. Long noncoding RNA TARID directs demethylation and activation of the tumor suppressor TCF21 via GADD45A. Mol Cell. 2014;55(4):604–14.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s) 2016